VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
IRMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
IRMDIRadimed Corporation
$82.31$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
IRMD logo

IRadimed Corporation

IRMD
NASDAQ · Medical Devices
$82.31
At close - Nov 18, 4:00 PM EST - USD
Market Cap$1.05B
P/E44.2x
52W High$107.90
Volume78.81K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Fortress Balance Sheet Funds Premium Margins Amid Growth Volatility

IRadimed's roughly 75% gross margin profile and net cash position, with $63.3M in cash against $14.6M in total liabilities and no reported debt, suggest a durable, self-funded medical device franchise.

GrowthStable
ProfitabilityStrong
ValuationExpensive
TechnicalsWeak
Explore valuation models
MARKET ACTION

IRMD price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

7/12 Beats

EPS beat 7 of last 12 quarters

02

Valuation risk

+75% Peers

P/E is 75% above peer median

03

Market leadership

RS 49 · Lag

Laggard (Underperforming 51% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Jan 30

Market performance

Price History →

Trailing total returns as of 11/19/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
IRMD-12.97%
S&P 500 (^GSPC)+6.88%
1-Year Return
IRMD-2.98%
S&P 500 (^GSPC)+10.62%
3-Year Return
IRMD+98.86%
S&P 500 (^GSPC)+55.61%
5-Year Return
IRMD+128.31%
S&P 500 (^GSPC)+57.18%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/EMedian
44.2x
Forward P/EExpansion
39.3x
EV/EBITDA60th %ile
32.7x
FCF YieldCash Flow
2.5%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
44.2x
36.7x
60th· Fair
EV/EBITDA
32.7x
28.6x
60th· Fair
Price/FCF
40.5x
55.3x
20th· Low
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$23.91-71.0%
Base (Fair)$39.05-54.2%
Bull$46.36-43.7%
$23.91 Bear$39.05 Base$46.36 Bull
Current Market Price: $82.31
Trades at a 110.8% premium to Base DCF ($39.05)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$84M+14.4% YoY
Net income FY25
$22M+16.9% YoY
Free cash flow FY25
$17M-2.5% YoY
Operating margin FY25
31.2%+1.2 pts YoY
ROIC (FY25)50.2%
Avg ROIC 5Y62.1%
ROE (TTM)23.9%
Piotroski Score5 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate7/12 (58%)
Revenue Beat Rate9/12 (75%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Oct 30, 2026
$0.55+0.0%
vs $0.55
$24M+3.1%
vs $23M
Q3 2026
Jul 31, 2026
$0.46+4.5%
vs $0.44
$20M+0.6%
vs $20M
Q2 2026
May 1, 2026
$0.49+8.9%
vs $0.45
$22M+3.1%
vs $21M
Q1 2026
Feb 10, 2026
$0.54+10.2%
vs $0.49
$23M+5.1%
vs $22M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Seeking Alpha·Oct 28, 2026
Riverwater Small Cap Strategy Q3 2026 Portfolio Update

During the third quarter of 2026, the Small Cap strategy slightly underperformed its benchmark, the Russell 2000 Index, in a period in which small cap stocks broadly declined. Top contributors include AtriCure and Red Violet; top detractors include Kodiak Gas Services and PDF Solutions. We initiated a position in IRadimed at the start of the quarter, replacing Talkspace after it was acquired.

Defense World·Oct 26, 2026
iRadimed (IRMD) Expected to Post Earnings on Friday

iRadimed (NASDAQ: IRMD - Get Free Report) is expected to be posting its Q3 2026 results before the market opens on Friday, October 30th. Analysts expect the company to announce earnings of $0.55 per share and revenue of $23.47 million for the quarter. iRadimed has set its FY 2026 guidance at 2.090-2.240 EPS and its Q3

GlobeNewsWire·Oct 23, 2026
IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026

ORLANDO, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 third quarter financial results before the market opens on Friday, October 30, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

GlobeNewsWire·Sep 23, 2026
IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference

ORLANDO, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today that it will participate in the 5th Annual ROTH Healthcare Opportunities Conference.

Filtered for IRadimed CorporationMore Headlines
04

Compare before deciding

Benchmark IRMD against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for IRadimed Corporation (IRMD)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
IRMD logoIRMDIRadimed CorporationCurrent
$82.31$1.05B44.1914.43%26.85%23.9%1.42%
LNTH logoLNTHLantheus Holdings, Inc.
$102.00$6.64B25.850.5%17.28%21.72%—
PRCT logoPRCTPROCEPT BioRobotics Corporation
$25.18$1.43B-12.5737.22%-32.6%-33.23%—
ANGO logoANGOAngioDynamics, Inc.
$11.32$467.88M-14.449.46%-10.12%-19.25%—
NVCR logoNVCRNovocure Ltd
$10.73$1.24B-10.298.28%-16.78%-35.81%—
GEHC logoGEHCGE HealthCare Technologies Inc.
$83.66$37.79B21.534.84%8.54%15.87%0.17%

Compare IRMD vs Peers

IRadimed Corporation (IRMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs LNTH

Most directly comparable listed peer for IRMD.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare IRMD against a more recognizable public peer.

Peer Set

Compare Top 5

vs LNTH, PRCT, ANGO, NVCR

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

IRMD SEC Filings & Documents

IRadimed Corporation (IRMD) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Oct 30, 2026·SEC

Material company update

Jul 31, 2026·SEC

Material company update

Jun 24, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 6, 2026·SEC

FY 2025

Mar 6, 2025·SEC

FY 2024

Mar 1, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Oct 30, 2026·SEC

FY 2026

Jul 31, 2026·SEC

FY 2026

May 1, 2026·SEC

Get notified when IRMD posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

IRMD Frequently Asked Questions

IRadimed Corporation (IRMD) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is IRadimed Corporation's revenue?

IRadimed Corporation (IRMD) reported $89.3M in revenue over the trailing twelve months. Revenue was $83.8M in fiscal year 2025. That is 991% more than the $7.7M of fiscal year 2012.

How fast is IRadimed Corporation growing?

IRadimed Corporation (IRMD) grew revenue by 11.0% over the trailing twelve months, compared with the twelve months before.

Is IRMD profitable?

Yes. IRadimed Corporation (IRMD) earned $24.0M in net income over the trailing twelve months (a 26.8% net margin).

Dividend & Returns
Does IRMD pay dividends?

Yes. IRadimed Corporation (IRMD) pays a dividend that yields 1.42% at the current price, a moderate yield.

What is IRMD's return on equity?

IRadimed Corporation (IRMD) had a return on equity (ROE) of 23.9% over the trailing twelve months. That is well above the market's typical 10-15%.

What is IRadimed Corporation's free cash flow?

IRadimed Corporation (IRMD) generated $25.9M in free cash flow over the trailing twelve months.

What if you invested $1,000 in IRMD back in 2012?

Total return calculator · dividends reinvested · 14+ years of data

See returns →